Viewing Study NCT06865651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-22 @ 3:56 PM
Study NCT ID: NCT06865651
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Remibrutinib View
None LOU064 View
None Chronic urticaria View
None CINDU View
None CSU View
None Symptomatic dermographism View
None Cold urticaria View
None Cholinergic urticaria View
None Heat urticaria View
None Solar urticaria View
None Delayed pressure urticaria View
None Aquagenic urticaria View
None Contact urticaria View